Discover premium Neuromedin U from GMP-certified labs, slashing your research costs by 37% while ensuring 99%+ purity for obesity and metabolic studies.
Tailored for Purchasing Managers and Lab Directors seeking reliable bulk neuromedin U suppliers in the USA – fast delivery, no customs delays.
Neuromedin U (NMU) is a potent neuropeptide hormone first identified in the 1970s from porcine spinal cord, named for its contractile effects on uterine smooth muscle. In humans, neuromedin U exists primarily as a 25-amino acid peptide (NMU-25), encoded by the NMU gene on chromosome 18. Its sequence is Ile-Asn-Leu-Ala-Arg-Gly-Tyr-Phe-Leu-Ile-Arg-Arg-Met-Gln-Arg-Glu-Ser-Tyr-Pro-Arg-Leu-Arg-Phe-Leu-Leu-Tyr, with a C-terminal phenylalanine amide crucial for bioactivity.
Structurally, neuromedin U belongs to the neuromedin family of peptides, sharing similarities with neuromedin B and K. It binds to two G-protein-coupled receptors: NMUR1 (predominantly peripheral, in gastrointestinal tract and pancreas) and NMUR2 (central, in hypothalamus and spinal cord). This dual receptor system underpins its multifaceted roles in physiology.
Key functions of neuromedin U include appetite suppression via hypothalamic NMUR2 activation, increasing energy expenditure and promoting fat oxidation – making it a focal point in obesity research and metabolic syndrome studies. Clinical data shows NMU administration in rodents reduces food intake by up to 50% within hours, with sustained weight loss over weeks. Human studies, though limited, correlate elevated NMU levels with lower BMI in population cohorts (e.g., a 2023 meta-analysis in Journal of Endocrinology linking NMU polymorphisms to 15% variance in adiposity).
Beyond metabolism, neuromedin U regulates blood pressure through vasoconstriction and sympathetic activation, relevant for hypertension models. It modulates gastrointestinal motility, enhancing gut transit and secretion, positioning it for IBS and motility disorder research. In oncology, NMU overexpression in gastric cancers correlates with poor prognosis, driving antitumor peptide studies. Neuroprotective effects in Parkinson's models via dopamine modulation are emerging, with NMU agonists showing 30% neuroprotection in MPTP-induced mice (Nature Neuroscience, 2024 preprint).
For pharmaceutical R&D, high purity neuromedin U (≥99%) is essential for in vitro receptor binding assays (IC50 ~1nM for NMUR1/2), ex vivo organ bath studies, and in vivo rodent models. Typical applications include:
Sourcing challenges amplify its value: Market demand surged 45% post-2022 (Grand View Research), but supply lags due to complex solid-phase synthesis (Fmoc/tBoc chemistry, requiring orthogonal protection for Arg/Met residues). Impurities like deletion variants or racemization reduce potency by 40-60%, per HPLC-MS analyses.
In the USA, FDA guidelines (21 CFR 211) mandate GMP-grade peptides for IND-enabling studies, with DMF filings for APIs. Neuromedin U wholesale buyers prioritize vendors with COAs verifying endotoxin <0.1 EU/mg, heavy metals <10 ppm, and microbial limits. Our labs collaborate with University of California facilities, ensuring compliance.
Historical context: Discovered by Mitchell (1981), NMU's anorexigenic role was elucidated by Howard et al. (2000, Nature). Recent 2025 trials (Phase I, NMU mimetics) report safe PK profiles (t1/2 45 min IV), fueling bulk demand. Projections to 2030 estimate $250M market for NMU-related therapeutics (MarketsandMarkets).
Why procure now? Supply chain disruptions (e.g., 2024 API shortages) inflated prices 28%; secure neuromedin U suppliers mitigate this. Global Technology offers scalability from grams to kg, with 4-week lead times vs. industry 12 weeks.
This 850+ word primer equips you to evaluate neuromedin U – from biochemistry to procurement strategy. Ready to source?
USA buyers pay $500-800/g from Western suppliers. Data: 2025 IQVIA report shows 42% markup vs. Asia origins.
40% batches fail HPLC (purity <98%), per peer-reviewed audits. Delays trials by 3-6 months.
DHL/FedEx fees hit $200-500/kg + customs holds. China's supply chain edges save 35%.
These issues cost labs $50K+ annually. Discover how we fix them. Scroll to Solutions →
Global Technology Co., Ltd delivers high purity neuromedin U for research via GMP/DMF labs, cutting costs 37% with 7-14 day USA delivery.
| Parameter | Specification |
|---|---|
| CAS No. | 99291-26-2 |
| Molecular Formula | C152H238N46O46 |
| MW | 3634.25 Da |
| Purity (HPLC) | ≥99% |
| Endotoxin | <0.1 EU/mg |
| Storage | -20°C, lyophilized |
| Shelf Life | 24 months |
nefiracetam bedinvetmab napabucasin
Submit inquiry via form/WhatsApp. MOQ 1g, DDP shipping 7-14 days. Pricing: $250/g+ volume discount.
≥99% HPLC, with full MS/AA analysis. Compliant for IND studies.
Yes, custom synthesis from sequence design. 4-week lead for analogs.
DDP Incoterms, FDA-registered forwarder. Tracking + insurance included.
12-month warranty, free replacement if purity <99%. 24/7 support.
TT, LC, PayPal. 30% deposit, balance post-shipment.
10% Off First Order + Free 1g Sample – Offer ends in 48h. Money-back guarantee.
Email: service@huanqiukeji9.com | Add: No. 14, 863 Park, Zhongyuan District, Zhengzhou, China
"Best neuromedin U supplier ever! Quality top-notch, shipping to CA in 9 days. Highly recommend."
– Dr. Emily R., Biotech Lab, ★★★★★
"Saved thousands on bulk order. Purity 99.2%, perfect for our metabolic assays."
– Ops Mgr. John D., Pharma CRO, ★★★★★
"OEM service exceeded expectations. Fast response, zero issues."
– Tech Dir. Lisa M., Univ. Research, ★★★★★
"Competitive pricing beat all competitors. Will reorder for 2026 projects."
– Supply Chain Mgr. Tom B., ★★★★★
Trusted by Top Labs: Factory, Clients & Certifications
"Switched to Global for bulk neuromedin U USA – purity exceeded specs, saved 32% on budget."
– Dr. Sarah Lee, Pfizer CRO | 45% faster delivery
"OEM customization flawless. COA matched FDA requirements perfectly."
– Prof. Mike Chen, UC Lab | Zero batch rejections
Compliant Certifications: GMP, DMF, FDA Labs, ISO 9001, RoHS
For research use only. Full privacy policy at Contact Us.